1,25(OH)2D3 suppression of Sp1/NF-Y transactivation of the human PTH promoter requires an intact AF-2 domain

被引：0
|
作者：
Koszewski, NJ
Alimov, AP
Park-Sarge, O
Sarge, KD
Malluche, HH
机构：
[1] Univ Kentucky, Div Nephrol Bone Mineral Metab, Med Ctr, Lexington, KY 40506 USA
[2] Univ Kentucky, Dept Physiol, Med Ctr, Lexington, KY 40506 USA
[3] Univ Kentucky, Dept Mol & Cellular Biochem, Med Ctr, Lexington, KY 40506 USA
来源：
BONE | 2005年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S463 / S463
页数：1
相关论文
共 50 条
  • [1] PRODUCTION OF 24,25(OH)2D3 AND 1,25(OH)2D3 BY HUMAN FORESKIN KERATINOCYTES - REGULATION BY 1,25(OH)2D3
    NEMANIC, M
    BIKLE, D
    FEDERATION PROCEEDINGS, 1983, 42 (05) : 1178 - 1178
  • [2] MODULATION OF THE HUMAN IMMUNODEFICIENCY VIRUS PROMOTER BY 1,25(OH)2D3
    WEBER, RD
    QUINLIVAN, E
    KENNEY, S
    COHEN, MS
    CLINICAL RESEARCH, 1989, 37 (02): : A567 - A567
  • [3] Comparison between 1α(OH)D3 and 1,25(OH)2D3 on the suppression of plasma PTH levels in uremic patients, evaluated by the 'whole' and 'intact' PTH assays
    Brandi, L
    Egfjord, M
    Olgaard, K
    NEPHRON CLINICAL PRACTICE, 2005, 99 (04): : C128 - C137
  • [4] CHANGES OF PTH,1,25(OH)2D3 AND BIOCHEMISTRY IN RENAL OSTEODYSTROPHY
    JIA, JK
    LOU, DX
    ZHU, B
    WANG, GY
    CHAO, HT
    DONG, DC
    KIDNEY INTERNATIONAL, 1992, 42 (02) : 499 - 499
  • [5] THE GONADS ARE TARGET ORGANS FOR 1,25(OH)2D3 DEMONSTRATION OF 1,25(OH)2D3 RECEPTORS AND IMPAIRED CAMP RESPONSE IN 1,25(OH)2D3 DEFICIENCY STATE (NX)
    MERKE, J
    KREUSSER, W
    RITZ, E
    ACTA ENDOCRINOLOGICA, 1983, 102 : 27 - 27
  • [6] 24,25(OH)2D3 ENHANCES THE CALCEMIC EFFECT OF 1,25(OH)2D3 IN INTACT AND PTX RATS
    WALD, H
    TRAVES, Y
    POPOVTZER, MM
    BONE, 1986, 7 (05) : 414 - 414
  • [7] Nutrigenomics of 1,25(OH)2D3 Action in the Intestine: Evidence for a Role of 1,25(OH)2D3 in Manganese Transport
    Li, Shanshan
    De La Cruz, Jessica
    Christakos, Sylvia
    Hur, Joseph
    Pellon-Cardenas, Oscar
    Verzi, Michael
    Shroyer, Noah
    Fleet, James
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 212 - 212
  • [8] CLINICAL-EVIDENCE ON THE INTERACTIONS BETWEEN PTH AND 1,25(OH)2D3
    SANTOS, F
    CHAN, JCM
    KIDNEY INTERNATIONAL, 1986, 29 (01) : 202 - 202
  • [9] Changes of PTH, 1,25（OH）2D3 and Biochemistry in Renal Osteodystrophy.
    Jia Jing-kang
    33(1):33.
    中华医学杂志(英文版), 1994, (07) : 21 - 21
  • [10] EFFECTS OF METABOLIC ALKALOSIS ON SERUM 1,25(OH)2D3 AND PTH IN THE RAT
    KITTAKA, M
    FAVUS, M
    LANGMAN, C
    BUSHINSKY, D
    KIDNEY INTERNATIONAL, 1987, 31 (01) : 351 - 351
12345